Brazil/USA trade dispute resolution a step further

22 June 2010

The long-running dispute between the USA and Brazil, which included imposing sanctions on US imports of pharmaceutical products, among total sanctions of $591 million (The Pharma Letter April 8), has moved a further step forward.

The Brazilian Foreign Board (CAMEX) - the agency that encompasses the ministers entitled to tailor the foreign trade policy - met last week and approved an agreement with the USA, which suspended until 2012 the applicability of commercial sanctions against the US subsidies to cotton producers, noted a blogger on IP Tango.

Both governments will sign a Memorandum of Understanding to establish a new set of negotiations, consultations and reforms until the US government finalize the elaboration of a new agricultural law by 2012.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical